We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Thyroid Function Tests Need Standardization

By LabMedica International staff writers
Posted on 01 Dec 2010
Laboratory testing is an essential tool for diagnosis and management of thyroid diseases, but the current status of standardization hampers the interchangeability of results.

An assessment has been made of the level of standardization and the quality of the performance of current routine assays such as human thyroid stimulating hormone (TSH), and free and total thyroid hormone in serum from apparently healthy donors.

A study carried out at Ghent University, (Ghent, Belgium), compared five different thyroid function assays including TSH, free thyroxine (FT4), free triiodothyronine (FT3), Total T4 (TT4) and total T3 (TT3) using one to several immunoanalyzers. More...
A second objective was to investigate the effect of mathematical recalibration of the results using their relationship to the overall mean (TSH) or the reference measurement procedure values of other thyroid hormones.

The need for standardization was shown to be highest for free thyroid hormone and total triiodothyronine measurements, while the majority of TSH and total thyroxine assays agreed within 10% of the reference. Most of the assays showed good performance with consistent results. However, some could benefit from improved precision, consistency of calibration, or within- and between-run stability. Recalibration eliminated any assay-specific bias that was found. The residual spread was due to within-method effects, but sample-related effects remained.

The authors concluded, "The studies confirmed the feasibility of standardization based on method comparison with native sera, but highlighted the need to resolve issues, such as sample-related effects. In view of the fact that in this phase the project worked with samples from individuals with euthyroid status, the next method comparison shall place emphasis on challenging the performance of the assays with clinical samples and expanding the covered measurement range.” The study was published in November 2010, in Clinical Chemistry and Laboratory Medicine.

Related Links:

Ghent University



Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
8-Channel Pipette
SAPPHIRE 20–300 µL
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.